Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives
Continuing Cardiology Education · 2016
DOI: 10.1002/cce2.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Continuing Cardiology Education, 2016. Verfasst von A. Tzikas und 1 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Left atrial appendage occlusion (LAAO) is a promising alternative to oral anti‐coagulation in patients with non‐valvular atrial fibrillation. Recently, four‐year results of PROTECT‐AF demonstrated superiority of LAAO in all‐cause mortality and stroke reduction compared to optimal medical treatment with warfarin. In this new era, it is important to identify the patients who would benefit more from LAAO and offer them priority for treatment. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193475/Activity.aspx
Zitieren
APA
Tzikas, A., & Lewalter, T. (2016). Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives. Continuing Cardiology Education. https://doi.org/10.1002/cce2.18
Vancouver
Tzikas A, Lewalter T. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives. Continuing Cardiology Education. 2016. doi:10.1002/cce2.18
BibTeX
@article{Tzikas2016,
author = {Tzikas, A. and Lewalter, T.},
title = {Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives},
journal = {Continuing Cardiology Education},
year = {2016},
doi = {10.1002/cce2.18}
}
EUVIMED